Spirometrix, Inc. (now Spirosure, Inc.) is a Pleasanton, California-based startup spearheading the development and commercialization of advanced breath-analysis devices for non-invasive management of chronic respiratory diseases. Established in 2011, the company's innovative sensors and algorithms are tailored for the diagnosis and treatment of conditions such as asthma, COPD, and chronic pulmonary hypertension, thereby addressing the pressing need for cost-effective preventative healthcare solutions. With a recent $15.00M Series C investment from NGK SPARK PLUG CO in January 2018, Spirometrix is positioned to further its impact within the Health Care and Medical Devices industries, solidifying its influence as a pioneer in non-invasive disease management technology.
No recent news or press coverage available for Spirometrix, Inc. (now Spirosure, Inc.).